Related Experiment Video

Updated: Aug 20, 2026

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging
05:10

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging

Published on: September 12, 2025

[Mucus physicochemical properties in children with ulcerative colitis]

Krystyna Grzybowska1, Krzysztof Gwoździński, Grazyna Zaleśna

  • 1Klinika Pediatrii i Gastroenterologii Instytutu Centrum Zdrowia Matki Polki w Lodzi.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|December 18, 2004
PubMed

Insights

This study found that colonic mucus changes with ulcerative colitis severity in children. Increased mucus protein and decreased viscosity correlate with disease severity, offering potential diagnostic markers.

Area of Science:

  • Gastroenterology and Clinical Biochemistry
  • Pediatric Inflammatory Bowel Disease Research

Context:

  • Ulcerative colitis (UC) is a chronic inflammatory bowel disease affecting the colon.
  • Understanding colonic mucus alterations is crucial for diagnosing and managing pediatric UC.
  • Current diagnostic markers may not fully capture disease heterogeneity.

Purpose:

  • To investigate the physicochemical properties of colonic mucus in children with UC.
  • To correlate mucus properties with disease severity based on the Truelove-Witts criteria.
  • To evaluate the potential of soluble mucus protein as a biomarker for UC severity.

Summary:

  • Thirty-six children (10-17 years) with UC were grouped by disease severity.
  • Colonic mucus was analyzed using SDS-PAGE, EPR, and spectrophotometry.
  • Results showed increased mucus protein concentration and decreased viscosity with increasing UC severity.

Impact:

  • Colonic mucus physicochemical properties vary significantly with UC severity in pediatric patients.
  • Soluble protein fraction in colonic mucus may serve as a valuable, objective marker for assessing UC severity.
  • These findings could lead to improved diagnostic tools and personalized treatment strategies for pediatric UC.

More Related Videos

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer08:47

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on: April 21, 2022

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids06:31

Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Published on: June 2, 2023

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.